Remdesivir manufacturer, Gilead, just set the price for the COVID-19 treatment: between $2,300 and $3,100 per patient. @icer_review estimates the treatment costs approx. $1 per vital to produce. $1.— Office of the State Treasurer (@PATreasurer) August 5, 2020
Real strong backbone you got there ya dork. I'm sure politely asking them will fix everything.
Shareholders settling everything with pistol duels would be way better
Then that "risk" they keep whining about would actually exist
I'd like to speak with the manager of capitalism please.